Research appearing in the Journal of Medicinal Chemistry shows for the first time SARS-CoV-2, the virus responsible for COVID-19, can be inhibited from replicating in living cell cultures using a ...

Long COVID continues to affect millions of people worldwide, and scientists are still trying to understand why some patients ...

A schematic diagram showing the significant contribution of SCoV2-induced altered mitochondrial dynamics and mitochondrial EGFR translocation in sustaining viral propagation. First, SCOV2 RNA and ...

A research team at Ruhr University Bochum, Germany, has identified a previously unknown cellular mechanism crucial to the replication of coronaviruses: c-Jun N-terminal kinase (JNK) is activated ...

In a recent study posted to the medRxiv* preprint server, researchers observe persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in severe coronavirus disease 2019 ...

The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication machinery to switch on reporter or therapeutic genes precisely in infected cells.

A new study has found that SARS-CoV-2, the virus that causes COVID-19, damages the genes of the mitochondria, the cell’s energy generators, causing dysfunction in organs other than the lungs that ...

Add Yahoo as a preferred source to see more of our stories on Google. Millions of people who recover from infections like COVID-19, influenza and glandular fever are affected by long-lasting symptoms.

Important differences in how the nasal cells of young and elderly people respond to the SARS-CoV-2 virus, could explain why children typically experience milder COVID-19 symptoms, a new study finds.